98633tms FDA to Consider Transcranial Magnetic Stimulation System
Remember transcranial magnetic stimulation (TMS), a noninvasive procedure in which electrical activity of the brain is “buzzed” by an alternating magnetic field, through magnetic induction? We’ve followed TMS for quite some time now, for its purported usefulness in depression, schizophrenia, migranes, and vision — not to mention its potential to induce temporary “Rain Man” – like savant states.
98633tms2 FDA to Consider Transcranial Magnetic Stimulation SystemAccording to the Associated Press, the FDA is planning to consider for approval a TMS device, developed for the treatment of major depression, called Neurostar System by Neuronetics.
To learn more about the Neurostar System, go to its product page…
Neuronetics’ technology page…
Flashbacks: Medgadget’s transcranial magnetic stimulation archives…